Metformin Improves Immunosuppressant Induced Hyperglycemia and Exocrine Apoptosis in Rats

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Transplantation

• Publication date

  2013-01-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0b013e318275a322PMID 23250335PMCID PMC12529965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radioimmunoassay.

  2020cited by this paper
• Should Metformin Be Our Antiglycemic Agent of Choice Post‐transplantation?

  2011cited by this paper
• Different Effects of FK506, Rapamycin, and Mycophenolate Mofetil on Glucose-Stimulated Insulin Release and Apoptosis in Human Islets

  2009cited by this paper
• Prediabetes in Patients Receiving Tacrolimus in the First Year After Kidney Transplantation: A Prospective and Multicenter Study

  2008cited by this paper
• Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

  2008cited by this paper
• New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression.

  2008cited by this paper
• Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients.

  2008cited by this paper
• mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes

  2008cited by this paper
• Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.

  2008cited by this paper
• Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.

  2008cited by this paper
• Incidence and risk factors of new-onset diabetes mellitus after renal transplantation.

  2008cited by this paper
• Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

  2007cited by this paper
• Rapamycin Impairs In Vivo Proliferation of Islet Beta-Cells

  2007cited by this paper
• Transplant-associated hyperglycemia: a new look at an old problem.

  2007cited by this paper
• An update on the Diabetes Prevention Program.

  2006cited by this paper
• The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

  2006cited by this paper
• Tacrolimus and Sirolimus Cause Insulin Resistance in Normal Sprague Dawley Rats

  2006cited by this paper
• The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.

  2006cited by this paper
• Regulation of pancreatic beta-cell mass.

  2005cited by this paper
• Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.

  2005cited by this paper
• New-Onset Diabetes after Kidney Transplantation: An Application of 2003 International Guidelines

  2005cited by this paper
• Image processing with ImageJ

  2004cited by this paper
• Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets.

  2003cited by this paper
• New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

  2003cited by this paper
• Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice.

  2003cited by this paper
• Determinants of insulin secretion after renal transplantation.

  2003cited by this paper
• Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait‐Listed and Transplanted Renal Allograft Recipients

  2003cited by this paper
• Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry.

  2001cited by this paper
• Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.

  2001cited by this paper
• Perspective: Postnatal Pancreatic β Cell Growth.

  2000cited by this paper
• Perspective: Postnatal pancreatic beta cell growth.

  2000cited by this paper
• A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1

  1997cited by this paper
• A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

  1997cited by this paper
• Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.

  1996cited by this paper
• Immunoassay of endogenous plasma insulin in man.

  1996cited by this paper
• A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development

  1993cited by this paper
• Radioimmunoassay: a probe for the fine structure of biologic systems.

  1978cited by this paper

• Biomimetic ferritin nanocages for synergistic co-delivery of metformin and rapamycin restore neurodevelopmental homeostasis in autism spectrum disorders

  2025cites this paper
• Tacrolimus and diabetic rodent models

  2025influential citation
• Posttransplant complications: molecular mechanisms and therapeutic interventions

  2024cites this paper
• Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post‐transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation

  2023cites this paper
• Post-Transplantation Diabetes Mellitus

  2020cites this paper
• Administration of metformin in renal transplant patients with post-transplant diabetes mellitus

  2019cites this paper
• Impact of Conversion From Cyclosporine to Tacrolimus on Glucose Metabolism and Cardiovascular Risk Profiles in Long-Term Stable Kidney Transplant Recipients.

  2019cites this paper
• Medical Complications After Kidney Transplantation: Early

  2018cites this paper
• mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions

  2017cites this paper
• Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

  2016cites this paper
• Strategies and Challenges in Clinical Trials Targeting Human Aging

  2016cites this paper
• Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats

  2016cites this paper
• Effects of addition of a dipeptidyl peptidase IV inhibitor to metformin on sirolimus-induced diabetes mellitus.

  2016cites this paper
• Cancer-drug induced insulin resistance: innocent bystander or unusual suspect.

  2015cites this paper
• Emerging treatments for post-transplantation diabetes mellitus

  2015cites this paper
• New-Onset Diabetes Mellitus After Transplantation in a Cynomolgus Macaque (Macaca fasicularis).

  2015cites this paper
• Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats.

  2014cites this paper
• Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents.

  2014cites this paper
• Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions

  2014cites this paper